Pacific Biosciences of California PACB
Pacific Biosciences Of California, Inc. · Nasdaq · Laboratory Analytical Instruments
$2.83+15.51%close on Oct. 28, 2026 · volume 35.0M · Yahoo Finance
Price, last 47 sessions
Our coverage
Nothing published yet.
Insider buying and selling
| Date | Insider | Trade | Shares | Avg. price | Value |
|---|---|---|---|---|---|
| Oct. 6, 2026 | James R. Gibson II See Remarks | Sold 10b5-1 plan | 661,815 | $3.11 | $2.06 million |
| Aug. 17, 2026 | Mark Van Oene See Remarks | Sold | 26,911 | $1.13 | $30,409 |
Open-market purchases and sales reported on SEC Form 4 filed since July 24, 2026; grants, option exercises and shares withheld for tax aren't shown. A trade under a 10b5-1 plan was scheduled in advance. Where a filing was amended, the amendment's figures are shown.
Recent SEC filings
All 6 →Results of operations and financial condition · Costs of exit or disposal activities · Departure/appointment of directors or officers · Regulation FD disclosure · Financial statements and exhibits